Literature DB >> 29862446

Phage display-derived antibody fragments against conserved regions of VacA toxin of Helicobacter pylori.

Farnaz Fahimi1,2, Shamim Sarhaddi2, Mehdi Fouladi1,2, Naser Samadi2, Javid Sadeghi3, Asal Golchin1, Mohammad Reza Tohidkia4, Jaleh Barar1,5, Yadollah Omidi6,7,8.   

Abstract

Infection with Helicobacter pylori may result in the emergence of gastric adenocarcinoma. Among various toxins assisting pathogenesis of H. pylori, the vacuolating cytotoxin A (VacA) is one of the most potent toxins known as the major cause of the peptic ulcer and gastric adenocarcinoma. To isolate single-chain variable fragments (scFvs) against two conserved regions of VacA, we capitalized on the phage display technology and a solution-phase biopanning (SPB). Characterization of scFvs was carried out by enzyme-linked immunosorbent assay (ELISA), immunoblotting, and surface plasmon resonance (SPR). Bioinformatics analyses were also performed in order to characterize the structural and functional properties of the isolated scFvs and the interaction(s) between the isolated antibodies (Ab)-antigen (Ag). After four rounds of biopanning, the positive colonies detected by scFv ELISA were harvested to extract the plasmids and perform sequencing. Of several colonies, three colonies showed high affinity to the VacA1 and two colonies for the VacA2. Further complementary examinations (e.g., sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), western blot, SPR, and flow cytometry) displayed the high affinity and specificity of the isolated scFvs to the VacA. Docking results revealed the interaction of the complementarity-determining regions (CDRs) with the VacA peptide. In conclusion, for the first time, we report on the isolation of several scFvs against conserved residues of VacA toxin with high affinity and specificity, which may be used as novel diagnostic/therapeutic tool in the H. pylori infection.

Entities:  

Keywords:  Antibody; Helicobacter pylori; Phage antibody display; VacA toxin; scFvs

Mesh:

Substances:

Year:  2018        PMID: 29862446     DOI: 10.1007/s00253-018-9068-4

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  4 in total

Review 1.  Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy.

Authors:  Kristian Daniel Ralph Roth; Esther Veronika Wenzel; Maximilian Ruschig; Stephan Steinke; Nora Langreder; Philip Alexander Heine; Kai-Thomas Schneider; Rico Ballmann; Viola Fühner; Philipp Kuhn; Thomas Schirrmann; André Frenzel; Stefan Dübel; Maren Schubert; Gustavo Marçal Schmidt Garcia Moreira; Federico Bertoglio; Giulio Russo; Michael Hust
Journal:  Front Cell Infect Microbiol       Date:  2021-07-07       Impact factor: 5.293

Review 2.  Bacteria-Mediated Oncogenesis and the Underlying Molecular Intricacies: What We Know So Far.

Authors:  Shashanka K Prasad; Smitha Bhat; Dharini Shashank; Akshatha C R; Sindhu R; Pornchai Rachtanapun; Devananda Devegowda; Prasanna K Santhekadur; Sarana Rose Sommano
Journal:  Front Oncol       Date:  2022-04-04       Impact factor: 5.738

3.  Implementation of a Design of Experiments to Improve Periplasmic Yield of Functional ScFv Antibodies in a Phage Display Platform.

Authors:  Marjan Abri Aghdam; Mohammad Reza Tohidkia; Elham Ghamghami; Asadollah Ahmadikhah; Morteza Khanmahamadi; Behzad Baradaran; Ahad Mokhtarzadeh
Journal:  Adv Pharm Bull       Date:  2021-07-03

Review 4.  Molecular Mechanism of Helicobacter pylori-Induced Gastric Cancer.

Authors:  Majid Alipour
Journal:  J Gastrointest Cancer       Date:  2020-09-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.